Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip

Eterna Therapeutics Inc. (NASDAQ: ERNA)


$2.08
-0.0100 ( -0.48% ) 1.1K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open


$2.08

Previous close


$2.09

Volume


1.1K

Market cap


$11.25M

Day range


$1.98 - $2.11

52 week range


$0.84 - $2.96

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 76 Nov 13, 2023
8-k 8K-related 12 Nov 01, 2023
8-k 8K-related 12 Oct 05, 2023
8-k/a 8K-related 12 Sep 26, 2023
3 Insider transactions 2 Sep 01, 2023
8-k 8K-related 12 Aug 31, 2023
4 Insider transactions 1 Aug 25, 2023
10-q Quarterly Reports 75 Aug 11, 2023
8-k 8K-related 13 Aug 10, 2023
4 Insider transactions 1 Aug 10, 2023

Latest News